anti-IL-18 antibody(Pyrotech)

N/A

Report date: 2026/05/14 20:00:28
First In Class

Base Information

Drug Nameanti-IL-18 antibody(Pyrotech)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of Actionanti-Interleukin 18
TargetsInterleukin 18
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesPyrotech (Beijing) Biotechnology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesPyrotech (Beijing) Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A